Publish with Us Search
Publish with Us

GenoMed Connect

ISSN: 3105-3645

Hanieh Yaghootkar
Editor-in-Chief

Hanieh Yaghootkar
Editor-in-Chief

View Profile

GenoMed Connect facilitates interdisciplinary collaboration in advancing genomic integration into medicine. We welcome diverse contributions covering genomic medicine, translational genomics, precision medicine, human genetics, microbial genomics, technological advances, and ethical/social implications.  This open-access journal follows a continuous publication model and is licensed under Creative Commons Attribution 4.0 (CC BY 4.0).

Volumes 3
Articles 20
Volume: 3, 2026
Submit Article Join Our Editorial Board Become a Reviewer
Download Flyer
Volumes

SCIFINITI ALERT!

Subscribe for research updates and exclusive content straight to your inbox

Open Access Policy:
All articles published in the journal “GenoMed Connect” are made accessible through an open-access model, released under the Creative Commons Attribution 4.0 (CC BY 4.0) license. This license facilitates the unrestricted dissemination of articles, encouraging widespread sharing and utilization of valuable research contributions.

Publication Charges:
There will be no article processing charges (APCs) for submissions made by March 31, 2026, and all articles will be available as Open Access.

Subject Categories:
Genomics, Medicine, Genetics

Article Template:
You are encouraged to use the template to format your article according to our guidelines. However, this is not mandatory, as our layout team will ensure all necessary adjustments are made after acceptance and prior to final publication.

Download Template

Target Audience:
GenoMed Connect is tailored for researchers, clinicians, scientists, and healthcare professionals engaged in advancing the integration of genomics and medicine.

Ethics Statement:
All articles published by GenoMed Connect adhere strictly to the ethical guidelines suggested by the Committee on Publication Ethics (COPE).  We execute a stringent peer-review procedure that meticulously assesses the originality, quality, and precision of the research we disseminate. We employ advanced tools to scrutinize the legitimacy of submitted content and maintain a firm zero-tolerance stance toward instances of plagiarism, data manipulation, or inappropriate authorship.
For further details, please review our comprehensive Publication Ethics and Integrity Guidelines.

Insights

More Insights

37 Days

Time to First Peer Review Decision

63 Days

Time to Final Acceptance

2 Days

Acceptance to First Online

Recent Updates

All Updates
GenoMed Connect welcomes Dr. Hanieh Yaghootkar as Editor-in-Chief
2024-03-03
Scifiniti launches new open access journal, GenoMed Connect
2024-03-01

Recent Articles

All Articles
Review Article

Available Online: 30 Dec 2025

Spatial Omics in Decoding Oral Squamous Cell Carcinoma Heterogeneity: Microenvironment Crosstalk and Multi-Omics Integration

Volume 2

Oral squamous cell carcinoma (OSCC) is a major issue in the sphere of head and neck cancer since it is very heterogeneous, which also leads to the poor treatment results and low survival rates in the advanced stages. Here, the review will discuss how spatial omics methods explore tumor heterogeneity in OSCC, which includes cellular, molecular, and immune microenvironment alterations..

https://doi.org/Registering DOI
Review Article

Available Online: 23 Dec 2025

A Century of Alkaptonuria: Evolving Insights into a Rare Metabolic Disorder

Volume 2

https://doi.org/Registering DOI
Research Article

Available Online: 22 Dec 2025

Effect of Conjugated siRNA-Gold Nanoparticles on antibiotic-resistance Integron class I Gene

Volume 2

https://doi.org/Registering DOI
Research Article

Published: 18 Dec 2025

AI-Driven Machine Learning Analysis in Major Depressive Disorder (MDD): Sex-Based Variations in Oxytocin and Clinical Profiles

Volume 2

https://doi.org/10.69709/GenomC.2025.100122
Share
Help